Human CD27/S152/S152. LPFS2 ORF/cDNA clone-Lentivirus particle (NM_001242)
Cat. No.: vGMLP002986
Pre-made Human CD27/S152/S152. LPFS2 Lentiviral expression plasmid for CD27 lentivirus packaging, CD27 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CD27/S152 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP002986 | Human CD27 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP002986 |
| Gene Name | CD27 |
| Accession Number | NM_001242 |
| Gene ID | 939 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 783 bp |
| Gene Alias | S152,S152. LPFS2,T14,TNFRSF7,Tp55 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCACGGCCACATCCCTGGTGGCTGTGCGTTCTGGGGACCCTGGTGGGGCTCTCAGCTACTCCAGCCCCCAAGAGCTGCCCAGAGAGGCACTACTGGGCTCAGGGAAAGCTGTGCTGCCAGATGTGTGAGCCAGGAACATTCCTCGTGAAGGACTGTGACCAGCATAGAAAGGCTGCTCAGTGTGATCCTTGCATACCGGGGGTCTCCTTCTCTCCTGACCACCACACCCGGCCCCACTGTGAGAGCTGTCGGCACTGTAACTCTGGTCTTCTCGTTCGCAACTGCACCATCACTGCCAATGCTGAGTGTGCCTGTCGCAATGGCTGGCAGTGCAGGGACAAGGAGTGCACCGAGTGTGATCCTCTTCCAAACCCTTCGCTGACCGCTCGGTCGTCTCAGGCCCTGAGCCCACACCCTCAGCCCACCCACTTACCTTATGTCAGTGAGATGCTGGAGGCCAGGACAGCTGGGCACATGCAGACTCTGGCTGACTTCAGGCAGCTGCCTGCCCGGACTCTCTCTACCCACTGGCCACCCCAAAGATCCCTGTGCAGCTCCGATTTTATTCGCATCCTTGTGATCTTCTCTGGAATGTTCCTTGTTTTCACCCTGGCCGGGGCCCTGTTCCTCCATCAACGAAGGAAATATAGATCAAACAAAGGAGAAAGTCCTGTGGAGCCTGCAGAGCCTTGTCATTACAGCTGCCCCAGGGAGGAGGAGGGCAGCACCATCCCCATCCAGGAGGATTACCGAAAACCGGAGCCTGCCTGCTCCCCCTGA |
| ORF Protein Sequence | MARPHPWWLCVLGTLVGLSATPAPKSCPERHYWAQGKLCCQMCEPGTFLVKDCDQHRKAAQCDPCIPGVSFSPDHHTRPHCESCRHCNSGLLVRNCTITANAECACRNGWQCRDKECTECDPLPNPSLTARSSQALSPHPQPTHLPYVSEMLEARTAGHMQTLADFRQLPARTLSTHWPPQRSLCSSDFIRILVIFSGMFLVFTLAGALFLHQRRKYRSNKGESPVEPAEPCHYSCPREEEGSTIPIQEDYRKPEPACSP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-614 | Pre-Made Varlilumab biosimilar, Whole mAb, Anti-CD27 Antibody: Anti-T14/S152/Tp55/TNFRSF7/S152. LPFS2 therapeutic antibody |
| Target Antibody | GM-Tg-g-T85554-Ab | Anti-CD27/ S152/ S152. LPFS2 monoclonal antibody |
| Target Antigen | GM-Tg-g-T85554-Ag | CD27 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP002986 | Human CD27 Lentivirus plasmid |
| ORF Viral Vector | vGMLP002986 | Human CD27 Lentivirus particle |
Target information
| Target ID | GM-T85554 |
| Target Name | CD27 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
939 |
| Gene ID |
100630357 (Equus caballus), 101091633 (Felis catus), 21940 (Mus musculus), 500318 (Rattus norvegicus) 512514 (Bos taurus), 611674 (Canis lupus familiaris), 939 (Homo sapiens) |
| Gene Symbols & Synonyms | CD27,Cd27,S152,Tp55,Tnfrsf7,T14,TNFRSF7,S152. LPFS2 |
| Target Alternative Names | CD27,CD27 antigen,CD27L receptor,Cd27,S152,S152. LPFS2,T-cell activation antigen CD27,T14,TNFRSF7,Tnfrsf7,Tp55,Tumor necrosis factor receptor superfamily member 7 |
| Uniprot Accession |
P26842,P41272
Additional SwissProt Accessions: P41272,P26842 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer, Dent disease |
| Disease from KEGG | Cytokine-cytokine receptor interaction |
| Gene Ensembl | ENSECAG00000011126, ENSMUSG00000030336, ENSBTAG00000014725, ENSCAFG00845029234, ENSG00000139193 |
| Target Classification | Pathway, Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


